Effects of selective inhibition of pde4 and pde7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs

Advances in Experimental Medicine and Biology

Volumn 756, Issue , 2013, Pages 57-64

  Mokry, Juraj ^a   Joskova, Marta ^a   Mokra, Daniela ^a   Christensen, Ingrid ^a   Nosalova, Gabriela ^a  

^a University Teaching Hospital in Martin   (Slovakia)

Author keywords

Acetylcholine; Airway resistance; Cough; Histamine; Inflammation; Ovalbumin; Phosphodiesterase inhibitors; Rolipram

Indexed keywords

2 METHYL 5 NITROBENZENESULFONIC ACID DIMETHYLAMIDE; ACETYLCHOLINE; HISTAMINE; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE VII; ROLIPRAM;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; COUGHING; DOWN REGULATION; DRUG MECHANISM; EXPERIMENTAL GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE CONTRACTION;

EID: 84867570082     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4549-0_8     Document Type: Conference Paper

References (22)

1. Antoniu, S. A. (2006). Ro flumilast for the treatment of chronic obstructive pulmonary disease. Current Opinion in Investigational Drugs, 7 , 412-417.
2. Beeh, K. M., Beier, J., Lerch, C., Schulz, A. K., & Buhl, R. (2004). Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Lung, 182 , 369-377.
3. Bender, A. T., & Beavo, J. A. (2006). Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacological Reviews, 58 , 488-520.
4. Chung, K. F. (2006). Phosphodiesterase inhibitors in airways disease. European Journal of Pharmacology, 533 , 110-117.
5. Fabbri, L. M., Beghe, B., Yasothan, U., & Kirkpatrick, P. (2010). Ro flumilast. Nature Reviews. Drug Discovery, 9 , 761-762.
6. Franova, S., Nosalova, G., Pechanova, O., & Sutovska, M. (2007). Red wine polyphenolic compounds inhibit tracheal smooth muscle contraction during allergen-induced hyperreactivity of the airways. Journal of Pharmacy and Pharmacology, 59 , 727-732.
7. Giembycz, M. A. (2005a). Life after PDE4: Overcoming adverse events with dual-speci fi city phosphodiesterase inhibitors. Current Opinion in Pharmacology, 5 , 238-244.
8. Giembycz, M. A. (2005b). Phosphodiesterase-4: Selective and dual-speci fi city inhibitors for the therapy of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society, 2 , 326-333.
9. Giembycz, M. A., & Field, S. K. (2010). Ro flumilast: First phosphodiesterase 4 inhibitor approved for treatment of COPD. Drug Design, Development and Therapy, 4 , 147-158.
10. Karish, S. B., & Gagnon, J. M. (2006). The potential role of ro flumilast: The new phosphodiesterase-4 inhibitor. The Annals of Pharmacotherapy, 40 , 1096-1104.
11. Lipworth, B. J. (2005). Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet, 365 , 167-175.
12. Mokra, D., & Mokry, J. (2010). Meconium aspiration syndrome. From pathomechanisms to treatment (1st ed., p. 130). New York: Nova Science Publishers.
13. Mokry, J., & Nosalova, G. (2007). Evaluation of the cough re fl ex and airway reactivity in toluene-and ovalbumininduced airway hyperresponsiveness. Journal of Physiology and Pharmacology, 58 (Suppl 5), 419-426.
14. Mokry, J., Mokra, D., Nosalova, G., Beharkova, M., & Feherova, Z. (2008). In fluence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity. Journal of Physiology and Pharmacology, 59 (Suppl. 6), 473-482.
15. Mokry, J., Nosalova, G., & Mokra, D. (2009). In fluence of xanthine derivatives on cough and airway reactivity in guinea pigs. Journal of Physiology and Pharmacology, 60 (Suppl 5), 87-91.
16. Nosalova, G., & Mokry, J. (2001). The mechanism of action of xanthine derivatives and suppression of cough. Acta Medica Martiniana, 1 , 14-18.
17. Rabe, K. F., Bateman, E. D., O'Donnel, D., Witte, S., Bredenbroker, D., & Bethke, T. D. (2005). Ro flumilast: An oral anti-in fl ammatory treatment for chronic obstructive pulmonary disease: A randomised controlled trial. Lancet, 366 , 563-571.
18. Smith, S. J., Cieslinski, L. B., Newton, R., Donnelly, L. E., Fenwick, P. S., Nicholson, A. G., Barnes, P. J., Barnette, M. S., & Giembycz, M. A. (2004). Discovery of BRL 50481 [3-(N, N-dimethylsulfonamido)-4-methyl- nitrobenzene], a selective inhibitor of phosphodiesterase 7: In vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes. Molecular Pharmacology, 66 , 1679-1689.
19. Spina, D., Landells, L. J., & Page, C. P. (1998). The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as antiin fl ammatory drugs. Clinical and Experimental Allergy, 28 (Suppl 3), 24-34.
20. Strapkova, A., Nosalova, G., Banovcin, P., & Giacova, D. (1995). Changes in airway smooth muscle reactivity after exposure to toluene. Studia Pneumologica et Phthiseologica, 55 , 263-271.
21. Sutovska, M., Franova, S., & Sutovsky, J. (2009). The in fluence of animal species on the relationship between ATPsensitive potassium ion channels and defense re fl exes of the airways. Bratislava Medical Journal, 110 (5), 269-275.
22. Usmani, O. S., Belvisi, M. G., Patel, H. J., Crispino, N., Birrell, M. A., Korbonits, M., Korbonits, D., & Barnes, P. J. (2005). Theobromine inhibits sensory nerve activation and cough. The FASEB Journal, 19 , 231-233.